Editorial
One year on: Are we ready for COVID?
Y un año después, ¿estamos preparados para la COVID?
David Peña-Oteroa, Salvador Bello Drondab,
, David Díaz-Pérezc, David de la Rosa Carrillod
Corresponding author
a Enfermería, Hospital Sierrallana, Subdirección de Cuidados del Servicio Cántabro de Salud, Miembro IDIVAL e IiSGM, Área de Enfermería Respiratoria-SEPAR, Torrelavega, Cantabria, Spain
b Servicio de Neumología, Hospital Universitario Miguel Servet, Zaragoza, Spain
c Enfermería, Hospital Universitario Nuestra Señora de Candelaria, Servicio Canario de Salud, Área de Enfermería Respiratoria-SEPAR, Santa Cruz de Tenerife, Spain
d Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Área TIR-SEPAR, Barcelona, Spain
Read
2762
Timeswas read the article
931
Total PDF
1831
Total HTML
Share statistics
array:24 [ "pii" => "S1579212921001944" "issn" => "15792129" "doi" => "10.1016/j.arbr.2021.05.022" "estado" => "S300" "fechaPublicacion" => "2021-08-01" "aid" => "2778" "copyright" => "SEPAR" "copyrightAnyo" => "2021" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Arch Bronconeumol. 2021;57:517-8" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0300289621000892" "issn" => "03002896" "doi" => "10.1016/j.arbres.2021.02.016" "estado" => "S300" "fechaPublicacion" => "2021-08-01" "aid" => "2778" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Arch Bronconeumol. 2021;57:517-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Y un año después, ¿estamos preparados para la COVID?" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "517" "paginaFinal" => "518" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "One Year On: Are We Ready for COVID?" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "David Peña-Otero, Salvador Bello Dronda, David Díaz-Pérez, David de la Rosa Carrillo" "autores" => array:4 [ 0 => array:2 [ "nombre" => "David" "apellidos" => "Peña-Otero" ] 1 => array:2 [ "nombre" => "Salvador" "apellidos" => "Bello Dronda" ] 2 => array:2 [ "nombre" => "David" "apellidos" => "Díaz-Pérez" ] 3 => array:2 [ "nombre" => "David" "apellidos" => "de la Rosa Carrillo" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1579212921001944" "doi" => "10.1016/j.arbr.2021.05.022" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212921001944?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289621000892?idApp=UINPBA00003Z" "url" => "/03002896/0000005700000008/v1_202108020527/S0300289621000892/v1_202108020527/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1579212921001956" "issn" => "15792129" "doi" => "10.1016/j.arbr.2021.05.023" "estado" => "S300" "fechaPublicacion" => "2021-08-01" "aid" => "2797" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Arch Bronconeumol. 2021;57:519-20" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "COPD is more than just lung function: Let’s not forget depression" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "519" "paginaFinal" => "520" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "EPOC más allá de la función pulmonar: no se olviden de la depresión" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "María-Teresa García-Sanz, Francisco-Javier González-Barcala" "autores" => array:2 [ 0 => array:2 [ "nombre" => "María-Teresa" "apellidos" => "García-Sanz" ] 1 => array:2 [ "nombre" => "Francisco-Javier" "apellidos" => "González-Barcala" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289621001113" "doi" => "10.1016/j.arbres.2021.03.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289621001113?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212921001956?idApp=UINPBA00003Z" "url" => "/15792129/0000005700000008/v1_202108020523/S1579212921001956/v1_202108020523/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1579212921001932" "issn" => "15792129" "doi" => "10.1016/j.arbr.2021.05.021" "estado" => "S300" "fechaPublicacion" => "2021-08-01" "aid" => "2724" "copyright" => "SEPAR" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "edi" "cita" => "Arch Bronconeumol. 2021;57:515-6" "abierto" => array:3 [ "ES" => false "ES2" => false "LATM" => false ] "gratuito" => false "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "Smoking-attributable mortality in Spain: <span class="elsevierStyleItalic">Quo Vadis?</span>" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "515" "paginaFinal" => "516" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Mortalidad atribuida al tabaquismo en España: ¿<span class="elsevierStyleItalic">Quo vadis</span>?" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Mónica Pérez-Ríos, Esteve Fernández, María José López" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Mónica" "apellidos" => "Pérez-Ríos" ] 1 => array:2 [ "nombre" => "Esteve" "apellidos" => "Fernández" ] 2 => array:2 [ "nombre" => "María José" "apellidos" => "López" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0300289621000211" "doi" => "10.1016/j.arbres.2020.12.035" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0300289621000211?idApp=UINPBA00003Z" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212921001932?idApp=UINPBA00003Z" "url" => "/15792129/0000005700000008/v1_202108020523/S1579212921001932/v1_202108020523/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Editorial</span>" "titulo" => "One year on: Are we ready for COVID?" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "517" "paginaFinal" => "518" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "David Peña-Otero, Salvador Bello Dronda, David Díaz-Pérez, David de la Rosa Carrillo" "autores" => array:4 [ 0 => array:3 [ "nombre" => "David" "apellidos" => "Peña-Otero" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 1 => array:4 [ "nombre" => "Salvador" "apellidos" => "Bello Dronda" "email" => array:1 [ 0 => "sbello@salud.aragon.es" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor0005" ] ] ] 2 => array:3 [ "nombre" => "David" "apellidos" => "Díaz-Pérez" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "David" "apellidos" => "de la Rosa Carrillo" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">d</span>" "identificador" => "aff0020" ] ] ] ] "afiliaciones" => array:4 [ 0 => array:3 [ "entidad" => "Enfermería, Hospital Sierrallana, Subdirección de Cuidados del Servicio Cántabro de Salud, Miembro IDIVAL e IiSGM, Área de Enfermería Respiratoria-SEPAR, Torrelavega, Cantabria, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Servicio de Neumología, Hospital Universitario Miguel Servet, Zaragoza, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Enfermería, Hospital Universitario Nuestra Señora de Candelaria, Servicio Canario de Salud, Área de Enfermería Respiratoria-SEPAR, Santa Cruz de Tenerife, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] 3 => array:3 [ "entidad" => "Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Área TIR-SEPAR, Barcelona, Spain" "etiqueta" => "d" "identificador" => "aff0020" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Y un año después, ¿estamos preparados para la COVID?" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">On February 15, 2020, we warned of the imminent pandemic expansion of the 2019-nCoV virus.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> Just one year later, we have a better understanding of the antigenic characteristics, replicative cycle and genome of SARS-CoV-2, and candidate therapeutic targets have been identified. The high transmissibility of this virus via aerosols has also been confirmed, a factor that we know increases the risk of contagion in indoor environments, even if safe distances are maintained. This means that more stringent preventive measures are needed, especially among health professionals, given the risk to which they are exposed in their clinical practice.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,3</span></a> The rate of Covid-19 infection among health professionals has been as high as 21.4%. It is essential that we understand the reasons for and consequences of this high infection rate, as not only are health workers at risk from these transmission mechanisms, their close and continuous contact with people affected by Covid-19 has also made them vectors of transmission.</p><p id="par0010" class="elsevierStylePara elsevierViewall">During this year, changes made in procedures and interventions as knowledge developed have generated confusion among professionals and given them the impression that the correct measures were being introduced late. The shortage of personal protective equipment and support systems for the most serious patients led the authorities to roll out plans for prioritizing and rationalizing the use of supplies, while material that offered better protection was reserved for professionals exposed to aerosol-generating procedures.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">The SANICOVI®<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> study concludes by recommending measures that include the appropriate management of preventive, protective, educational, and organizational resources, both human and material. This not only prevents infections among healthcare professionals, but also ensures safer patient care. Workloads must be adjusted according to the care setting, and prevention procedures must be reinforced, training improved, and protocols disseminated and implemented to provide tailored protective measures.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Covid-19 diagnosis has increased with the incorporation of rapid tests that detect viral antigens or agglutinating antibodies, thus improving detection in the acute or convalescent phases. The sensitivity and specificity of each test depend on the stage of infection, so each one has a maximum effective period beyond which its results may be erroneous.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> Each test, therefore, must be selected according to time and circumstance.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a></p><p id="par0025" class="elsevierStylePara elsevierViewall">The course of Covid-19, characterized by an initial viral phase followed by a hyperinflammatory phase and a prothrombotic phase, is better characterized. All 3 phases impact on the various manifestations of the disease.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> Several prognostic factors have also been identified that have significantly influenced the management of patients during the months of the pandemic,<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> while the early, unproven use of lopinavir/ritonavir, hydroxychloroquine, and azithromycin has been stopped after they were shown to be ineffective in trials.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The current therapeutic gold standard is oxygen therapy; high-flow oxygen therapy has emerged as an essential modality, and the need to develop intermediate respiratory care units is clear. In these units, the need for orotracheal intubation (OTI), a procedure associated with complications and mortality (OTI 54% vs. non-OTI 7%), is significantly lower thanks to non-invasive mechanical ventilation and high-dependence care (e.g. proning).<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> In terms of medical treatment, we continue to use remdesivir as an antiviral, dexamethasone or other steroids as anti-inflammatories,<a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> and anticoagulation to prevent or treat thromboembolic disease, despite their obvious limitations. Tocilizumab, an IL-6 receptor blocker, continues to be used, despite conflicting results in clinical trials.</p><p id="par0035" class="elsevierStylePara elsevierViewall">Promising new data are being obtained with convalescent plasma, hyperimmune gammaglobulin, and monoclonal antibodies that neutralize viral epitopes, such as bamlanivimab or casirivimab plus imdevinab or etesevimab.<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> The FDA has authorized bamlanivinab alone or in combination with etesevinab for mild-to-moderate non-hospitalized patients. Pending further evidence, the antiparasitic ivermectin, the JAK inhibitor baricitinib, and IL-1 inhibitors are not yet recommended due to lack of data.<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> Two trials have shown that colchicine shortened recovery time and decreased hospitalizations and complications. In preclinical studies, plitidepsin, approved for multiple myeloma, has recently shown 27.5 times higher anti-SARS-CoV-2 activity than remdesivir.</p><p id="par0040" class="elsevierStylePara elsevierViewall">Fortunately, in contrast to the scant progress made in therapy, several vaccines have been authorized in just 10 months, including novel mRNA vaccines (Pfizer, Moderna), vector-based vaccines, similar to those used for Ebola (Astra-Zeneca), and other vaccines in the pipeline, such as mRNA (CureVac) and vector-based products (Janssen and the Russian Gamaleya) and adjuvanted subunit vaccines (Novavax, Sanofi-GSK).<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> All of them target the spike (S) protein.</p><p id="par0045" class="elsevierStylePara elsevierViewall">The very high viral replication has led to the appearance of mutant variants, including spike mutations, which demand close surveillance. Asian countries prioritized traditional techniques (inactivated virus) that are less potent but offer more viral targets. Current vaccines are safe and very effective, although the duration of immunity is not known. Nor is it known whether they will avert disease or infection by preventing transmission from vaccinated individuals. Some interesting projects are investigating apparently powerful mucosal vaccines that offer sterilizing immunity. All the evidence suggests that we will need to receive more than one vaccine.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Covid-19 causes persistent symptoms in most patients (fatigue, muscle weakness, difficulty sleeping, anxiety, or depression).<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> The long-term complications remain unknown. In the acute phase, this infection has put a stop to humanized healthcare and forced hospitals to restrict, or even ban, patient visiting. Despite efforts to improve the response capacity of care homes, health centers, and hospitals, the pandemic is generating delays in care<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> and limiting active user participation. Wherever possible, the switch to telemedicine has accelerated, but are we prepared?</p><p id="par0055" class="elsevierStylePara elsevierViewall">After one year, we can say that activities associated with Covid-19 biosecurity and treatment, if they are to be effective, must be backed up by high-quality science and evidence. “Evidence-based policy”<a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> must count from the outset on the collaboration of all actors involved in current and future challenges. In addition to the impact on the general population, the effects on health professionals are beginning to be make themselves felt, given the generalized accumulation of working hours, infections, and, not least, moral distress.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Peña-Otero D, Bello Dronda S, Díaz-Pérez D, de la Rosa Carrillo D, Y un año después, ¿estamos preparados para la COVID? Arch Bronconeumol. 2021;57:517–518.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:16 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Are we ready for the new coronavirus?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Peña-Otero" 1 => "D. Díaz-Pérez" 2 => "D. de-la-Rosa-Carrillo" 3 => "S. Bello-Dronda" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.arbr.2020.02.003" "Revista" => array:6 [ "tituloSerie" => "Arch Bronconeumol" "fecha" => "2020" "volumen" => "56" "paginaInicial" => "195" "paginaFinal" => "196" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34170990" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Aerosol transmission of SARS-CoV-2? Evidence, prevention and control" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "S. Tang" 1 => "Y. Mao" 2 => "R.M. Jones" 3 => "Q. Tan" 4 => "J.S. Ji" 5 => "N. Li" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Environ Int" "fecha" => "2020" "volumen" => "144" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Medidas de protección individual y colectiva en la Covid-19" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "D. Peña Otero" 1 => "M. Eguillor Mutiloa" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Patol Respir" "fecha" => "2020" "volumen" => "23 Supl. 3" "paginaInicial" => "S268" "paginaFinal" => "71" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Mascarillas como equipo de protección individual durante la pandemia de COVID-19: cómo, cuándo y cuáles deben utilizarse" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.M. Aranaz Andrés" 1 => "M.T. Gea Velázquez de Castro" 2 => "J. Vicente-Guijarro" 3 => "J. Beltrán Peribáñez" 4 => "M. García Haro" 5 => "J.L. Valencia-Martín" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jhqr.2020.06.001" "Revista" => array:6 [ "tituloSerie" => "J Healthc Qual Res" "fecha" => "2020" "volumen" => "35" "paginaInicial" => "245" "paginaFinal" => "252" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32680724" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Factores relacionados con el contagio por SARS-CoV-2 en profesionales de la salud en España. Proyecto SANICOVI" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S. Grupo" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Enferm Clin" "fecha" => "2020" "volumen" => "30" "paginaInicial" => "360" "paginaFinal" => "370" ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Interpreting diagnostic tests for SARS-CoV-2" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N. Sethuraman" 1 => "S.S. Jeremiah" 2 => "A. Ryo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1001/jama.2020.8259" "Revista" => array:6 [ "tituloSerie" => "JAMA" "fecha" => "2020" "volumen" => "323" "paginaInicial" => "2249" "paginaFinal" => "2251" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32374370" "web" => "Medline" ] ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Inflammation, thrombosis, and destruction: the three-headed cerberus of trauma- and SARS-CoV-2-induced ARDS" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L. Lupu" 1 => "A. Palmer" 2 => "M. Huber-Lang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3389/fimmu.2020.624547" "Revista" => array:4 [ "tituloSerie" => "Front Immunol" "fecha" => "2020" "volumen" => "11" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33552089" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Predictors of COVID-19 severity: a systematic review and meta-analysis" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M. Mudatsir" 1 => "J.K. Fajar" 2 => "L. Wulandari" 3 => "G. Soegiarto" 4 => "M. Ilmawan" 5 => "Y. Purnamasari" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.12688/f1000research.26186.2" "Revista" => array:5 [ "tituloSerie" => "F1000Research" "fecha" => "2020" "volumen" => "9" "paginaInicial" => "1107" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33163160" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Outcomes of an intermediate respiratory care unit in the COVID-19 pandemic" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.C. Hernandez-Rubio" 1 => "M.S. Abad" 2 => "A.Y. Leon" 3 => "G.D. Higuera" 4 => "L.G. Rodriguez" 5 => "C.G. Torrejon" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0244157" "Revista" => array:4 [ "tituloSerie" => "PLoS One" "fecha" => "2020" "volumen" => "15" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33362259" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Dexamethasone in hospitalized patients with Covid-19 — preliminary Report" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "P. Horby" 1 => "W.S. Lim" 2 => "J.R. Emberson" 3 => "M. Mafham" 4 => "J.L. Bell" 5 => "L. Linsell" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2021436" "Revista" => array:7 [ "tituloSerie" => "N Engl J Med" "fecha" => "2020" "volumen" => "384" "paginaInicial" => "693" "paginaFinal" => "704" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/32678530" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0266613818303346" "estado" => "S300" "issn" => "02666138" ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D.M. Weinreich" 1 => "S. Sivapalasingam" 2 => "T. Norton" 3 => "S. Ali" 4 => "H. Gao" 5 => "R. Bhore" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMoa2035002" "Revista" => array:6 [ "tituloSerie" => "N Engl J Med" "fecha" => "2021" "volumen" => "384" "paginaInicial" => "238" "paginaFinal" => "251" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33332778" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Coronavirus disease 2019 (COVID- 19) treatment guidelines" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "COVID-19 Treatment Guidelines Panel" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "WWW" => array:2 [ "link" => "https://www.covid19treatmentguidelines.nih.gov/" "fecha" => "2021" ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "COVID-19: a review of therapeutic strategies and vaccine candidates" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "V. Izda" 1 => "M.A. Jeffries" 2 => "A.H. Sawalha" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Clin Immunol" "fecha" => "2021" "volumen" => "222" ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "6-month consequences of COVID-19 in patients discharged from hospital: a cohort study" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "C. Huang" 1 => "L. Huang" 2 => "Y. Wang" 3 => "X. Li" 4 => "L. Ren" 5 => "X. Gu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/S0140-6736(20)32656-8" "Revista" => array:6 [ "tituloSerie" => "Lancet" "fecha" => "2021" "volumen" => "397" "paginaInicial" => "220" "paginaFinal" => "232" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/33428867" "web" => "Medline" ] ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficiency is not enough. Ethical analysis and recommendations for the allocation of scarce resources in a pandemic situation" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J. Hortal-Carmona" 1 => "J. Padilla-Bernáldez" 2 => "M. Melguizo-Jiménez" 3 => "T. Ausín" 4 => "M. Cruz-Piqueras" 5 => "M.T. López de la Vieja" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.gaceta.2020.07.006" "Revista" => array:4 [ "tituloSerie" => "Gac Sanit" "fecha" => "2021" "paginaInicial" => "30192" "paginaFinal" => "30198" ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "80 questions for UK biological security" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "L. Kemp" 1 => "D.C. Aldridge" 2 => "O. Booy" 3 => "H. Bower" 4 => "D. Browne" 5 => "M. Burgmann" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1371/journal.pone.0249615" "Revista" => array:4 [ "tituloSerie" => "PLoS One" "fecha" => "2021" "volumen" => "16" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34329319" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15792129/0000005700000008/v1_202108020523/S1579212921001944/v1_202108020523/en/main.assets" "Apartado" => array:4 [ "identificador" => "45360" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Editorials" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15792129/0000005700000008/v1_202108020523/S1579212921001944/v1_202108020523/en/main.pdf?idApp=UINPBA00003Z&text.app=https://archbronconeumol.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1579212921001944?idApp=UINPBA00003Z" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 November | 4 | 3 | 7 |
| 2024 October | 39 | 11 | 50 |
| 2024 September | 49 | 14 | 63 |
| 2024 August | 70 | 43 | 113 |
| 2024 July | 59 | 17 | 76 |
| 2024 June | 72 | 22 | 94 |
| 2024 May | 81 | 27 | 108 |
| 2024 April | 42 | 15 | 57 |
| 2024 March | 60 | 22 | 82 |
| 2024 February | 46 | 29 | 75 |
| 2024 January | 43 | 26 | 69 |
| 2023 December | 38 | 19 | 57 |
| 2023 November | 49 | 22 | 71 |
| 2023 October | 37 | 25 | 62 |
| 2023 September | 38 | 30 | 68 |
| 2023 August | 43 | 35 | 78 |
| 2023 July | 39 | 20 | 59 |
| 2023 June | 43 | 16 | 59 |
| 2023 May | 47 | 13 | 60 |
| 2023 April | 34 | 18 | 52 |
| 2023 March | 81 | 36 | 117 |
| 2023 February | 51 | 19 | 70 |
| 2023 January | 48 | 39 | 87 |
| 2022 December | 60 | 43 | 103 |
| 2022 November | 85 | 22 | 107 |
| 2022 October | 57 | 37 | 94 |
| 2022 September | 41 | 31 | 72 |
| 2022 August | 51 | 44 | 95 |
| 2022 July | 65 | 39 | 104 |
| 2022 June | 75 | 35 | 110 |
| 2022 May | 67 | 37 | 104 |
| 2022 April | 55 | 44 | 99 |
| 2022 March | 61 | 47 | 108 |
| 2022 February | 27 | 20 | 47 |
| 2022 January | 13 | 0 | 13 |
| 2021 December | 31 | 6 | 37 |
| 2021 November | 18 | 3 | 21 |
| 2021 September | 1 | 0 | 1 |
| 2021 August | 10 | 2 | 12 |
| 2021 July | 1 | 0 | 1 |
Show all
